New concepts in herpes simplex virus vaccine development: notes from the battlefield

Lipopeptide antigens applied to intravaginal mucosal epithelium are taken up by mucosal resident antigen-presenting cells (APCs), especially DCs/pDCs, which are activated and migrate out of the mucosal inductive sites into the mucosal effector sites of draining lymph nodes where antigen presentation to T cells occurs, resulting in a strong local mucosal immune response. The mucosal immunization with a multivalent lipopeptide vaccine targeting TLR-2 induces an immune mechanism that bridges innate immunity to the ‘asymptomatic’ epitope-specific adaptive T-cell response. DCs are activated through recognition of the lipopeptide by TLR-2 receptors molecules. This triggered activation of the MyD88-dependent pathway and leads to the production of inflammatory cytokines (IL-12, IL-6 and TNF-α), and to phenotypic maturation of APCs (i.e., upregulation of costimulatory and MHC molecules on DCs surface). The multiepitope lipopeptide vaccine is captured, processed and presented by MHC molecules on the matured DCs to T lymphocytes (signal 1: MHC/TCR interaction). This is not sufficient to activate naive T lymphocytes, which need an additional signal from costimulatory molecules (signal 2: B7/CD28), of which expression on DCs is induced by TLR-2 stimulation. Activated T lymphocytes become further differentiated to effector T lymphocytes by stimulation with cytokines such as IL-12.DC: Dendritic cell; HSV: Herpes simplex virus; HTL: Helper T lymphocyte; MyD88: Myeloid differentiation primary response gene 88; pDC: Plasmacytoid dendritic cell; TCR: T-cell receptor; TLR: Toll-like receptor.
New concepts in herpes simplex virus vaccine development: notes from the battlefield

Publication

New concepts in herpes simplex virus vaccine development: notes from the battlefield. () Gargi Dasgupta, et al. Expert Rev Vaccines. ;8(8):1023-1035. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Drosophila melanogaster Invertebrates (DC DC ncbigene_symbol dc 44088
Drosophila melanogaster Invertebrates and AND ncbigene_synonym CkIIbeta 32132
Drosophila melanogaster Invertebrates and AND ncbigene_synonym Andorra 32798
Drosophila melanogaster Invertebrates and AND ncbigene_synonym Anp 43595
Drosophila melanogaster Invertebrates and AND ncbigene_synonym Acam 44913
Drosophila melanogaster Invertebrates TNF-a) TNFA ncbigene_synonym egr 36054
Drosophila melanogaster Invertebrates TLR2 TLR2 ncbigene_symbol tlr-2 44349
Drosophila melanogaster Invertebrates MyD88 MYD88 ncbigene_symbol Myd88 35956
Drosophila melanogaster Invertebrates МНСТCR CR ncbigene_symbol CR 5657006
Drosophila melanogaster Invertebrates МНСТCR CCR ncbigene_synonym Cpr 33883
Drosophila melanogaster Invertebrates Rev. REV ncbigene_symbol Rev 45924
Homo sapiens Primates pDC) PDC ncbigene_symbol PDC 5132
Homo sapiens Primates pDC) PDC ncbigene_synonym PNKD 25953
Homo sapiens Primates CD4 CD4 ncbigene_symbol CD4 920
Homo sapiens Primates CD8 CD8 ncbigene_synonym CD8A 925
Homo sapiens Primates CD8 CD8 famplex_relations CD8B 926
Homo sapiens Primates IL-6 IL-6 ncbigene_synonym IL6 3569
Homo sapiens Primates TNF-a) TNFA ncbigene_synonym TNF 7124
Homo sapiens Primates (IL-12, IL12 famplex_relations IL12A 3592
Homo sapiens Primates (IL-12, IL12 famplex_relations IL12B 3593
Homo sapiens Primates TLR2 TLR2 ncbigene_symbol TLR2 7097
Homo sapiens Primates MyD88 MYD88 ncbigene_symbol MYD88 4615

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID